| Product Code: ETC11945733 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The China endovascular treatment devices market is experiencing significant growth driven by factors such as the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, and advancements in technology. The market includes a wide range of devices such as stents, catheters, guidewires, and embolic protection devices used in the treatment of conditions like peripheral artery disease, coronary artery disease, and aneurysms. Key players in the market are investing in research and development to introduce innovative products, while strategic collaborations and partnerships are also common to enhance market presence. Government initiatives to improve healthcare infrastructure and increase access to advanced medical treatments are further fueling market growth in China. The market is expected to continue expanding as the demand for endovascular treatments rises among the country`s aging population.
The China endovascular treatment devices market is experiencing significant growth driven by several key trends. There is a rising prevalence of cardiovascular diseases and a growing aging population in China, leading to an increased demand for minimally invasive treatment options. Technological advancements in endovascular devices, such as stents, catheters, and guidewires, are improving treatment outcomes and reducing procedural risks. Additionally, the government`s initiatives to improve healthcare infrastructure and increase access to advanced medical treatments are further fueling market growth. Market players are focusing on product innovation, strategic collaborations, and expanding their presence in tier 2 and tier 3 cities to capitalize on the expanding market opportunities in China`s endovascular treatment devices sector.
In the China endovascular treatment devices market, challenges are primarily related to regulatory hurdles, market access barriers, and intense competition. The regulatory environment in China can be complex and strict, requiring thorough approvals and compliance with evolving standards. Market access barriers, such as pricing pressures and reimbursement challenges, can hinder the adoption of advanced endovascular devices. Additionally, the market is highly competitive with both local and international players vying for market share, leading to pricing wars and the need for constant innovation to stay ahead. Overall, navigating these challenges requires companies to establish strong relationships with regulatory bodies, adapt to local market dynamics, and differentiate their products effectively to succeed in the competitive landscape of the China endovascular treatment devices market.
The China endovascular treatment devices market presents significant investment opportunities due to the growing prevalence of cardiovascular diseases in the country, coupled with increasing awareness and adoption of minimally invasive procedures. Key areas for investment include innovative stent technologies, embolization devices, catheters, and guidewires. With the Chinese government`s focus on improving healthcare infrastructure and access to advanced medical treatments, there is a favorable regulatory environment for the development and commercialization of endovascular devices. Additionally, partnerships with local hospitals and healthcare providers can enhance market penetration and facilitate product uptake. Overall, investing in the China endovascular treatment devices market offers potential for growth and returns as the demand for minimally invasive cardiovascular procedures continues to rise in the country.
The Chinese government has implemented various policies to regulate and support the endovascular treatment devices market. Key policies include the Medical Device Regulations, which set standards for product registration, manufacturing, and distribution. Additionally, the government has established the National Reimbursement Drug List (NRDL) to determine which medical devices are eligible for reimbursement under the public health insurance system. To promote innovation and development in the sector, the government has introduced incentives such as tax breaks and funding opportunities for research and development of new endovascular treatment devices. Overall, these policies aim to ensure quality and safety standards, enhance market access, and drive growth in the China endovascular treatment devices market.
The China endovascular treatment devices market is poised for significant growth in the coming years, driven by factors such as the increasing prevalence of cardiovascular diseases, rising geriatric population, and advancements in healthcare infrastructure. With a growing demand for minimally invasive procedures and a shift towards outpatient treatments, the market for endovascular devices is expected to expand rapidly. Additionally, the government`s initiatives to improve healthcare access and affordability for the population will further propel market growth. Key players in the industry are focusing on product innovation and strategic collaborations to gain a competitive edge in this evolving market landscape. Overall, the China endovascular treatment devices market is anticipated to experience robust growth opportunities and technological advancements in the foreseeable future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Endovascular Treatment Devices Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Endovascular Treatment Devices Market Revenues & Volume, 2021 & 2031F |
3.3 China Endovascular Treatment Devices Market - Industry Life Cycle |
3.4 China Endovascular Treatment Devices Market - Porter's Five Forces |
3.5 China Endovascular Treatment Devices Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 China Endovascular Treatment Devices Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.7 China Endovascular Treatment Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Endovascular Treatment Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in China |
4.2.2 Technological advancements in endovascular treatment devices |
4.2.3 Growing adoption of minimally invasive procedures in healthcare |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for product approvals |
4.3.2 High cost associated with endovascular treatment devices |
4.3.3 Limited availability of skilled healthcare professionals for performing endovascular procedures |
5 China Endovascular Treatment Devices Market Trends |
6 China Endovascular Treatment Devices Market, By Types |
6.1 China Endovascular Treatment Devices Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 China Endovascular Treatment Devices Market Revenues & Volume, By Product, 2021 - 2031F |
6.1.3 China Endovascular Treatment Devices Market Revenues & Volume, By Percutaneous endovascular aneurysm repair (EVAR), 2021 - 2031F |
6.1.4 China Endovascular Treatment Devices Market Revenues & Volume, By Fenestrated EVAR, 2021 - 2031F |
6.1.5 China Endovascular Treatment Devices Market Revenues & Volume, By Aortic stents Biodegradable Stents, 2021 - 2031F |
6.1.6 China Endovascular Treatment Devices Market Revenues & Volume, By Self-expanding Nitinol Stents, 2021 - 2031F |
6.1.7 China Endovascular Treatment Devices Market Revenues & Volume, By Thoracic aortic aneurysms grafts, 2021 - 2031F |
6.1.8 China Endovascular Treatment Devices Market Revenues & Volume, By Other Devices, 2021 - 2029F |
6.2 China Endovascular Treatment Devices Market, By Procedure |
6.2.1 Overview and Analysis |
6.2.2 China Endovascular Treatment Devices Market Revenues & Volume, By Balloon Angioplasty, 2021 - 2031F |
6.2.3 China Endovascular Treatment Devices Market Revenues & Volume, By Angioplasty with Stent Placement, 2021 - 2031F |
6.2.4 China Endovascular Treatment Devices Market Revenues & Volume, By Thrombolysis, 2021 - 2031F |
6.2.5 China Endovascular Treatment Devices Market Revenues & Volume, By Renal Artery Angioplasty and Stenting, 2021 - 2031F |
6.2.6 China Endovascular Treatment Devices Market Revenues & Volume, By Transfemoral Carotid Artery Stenting, 2021 - 2031F |
6.2.7 China Endovascular Treatment Devices Market Revenues & Volume, By Transcarotid Artery Revascularization, 2021 - 2029F |
6.2.8 China Endovascular Treatment Devices Market Revenues & Volume, By Others, 2021 - 2029F |
6.2.9 China Endovascular Treatment Devices Market Revenues & Volume, By Others, 2021 - 2029F |
6.3 China Endovascular Treatment Devices Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 China Endovascular Treatment Devices Market Revenues & Volume, By Pulmonary, 2021 - 2031F |
6.3.3 China Endovascular Treatment Devices Market Revenues & Volume, By Vascular, 2021 - 2031F |
6.3.4 China Endovascular Treatment Devices Market Revenues & Volume, By Cardiology Surgery, 2021 - 2031F |
6.3.5 China Endovascular Treatment Devices Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.3.6 China Endovascular Treatment Devices Market Revenues & Volume, By Radiology, 2021 - 2031F |
7 China Endovascular Treatment Devices Market Import-Export Trade Statistics |
7.1 China Endovascular Treatment Devices Market Export to Major Countries |
7.2 China Endovascular Treatment Devices Market Imports from Major Countries |
8 China Endovascular Treatment Devices Market Key Performance Indicators |
8.1 Number of endovascular procedures performed annually in China |
8.2 Adoption rate of new endovascular treatment technologies |
8.3 Average waiting time for endovascular treatment procedures in hospitals |
9 China Endovascular Treatment Devices Market - Opportunity Assessment |
9.1 China Endovascular Treatment Devices Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 China Endovascular Treatment Devices Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.3 China Endovascular Treatment Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Endovascular Treatment Devices Market - Competitive Landscape |
10.1 China Endovascular Treatment Devices Market Revenue Share, By Companies, 2024 |
10.2 China Endovascular Treatment Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here